abacavir

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

STARLITE for Unresectable High-Grade Gliomas

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir

Study of Options for Second-Line Effective Combination Therapy (SELECT)

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide

Abacavir and Lamivudine PK in Children

Determining the Effect of Abacavir on Platelet Activation

Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients

Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis

Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity

Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects